{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "New York",
      "state": "NY",
      "country": "United States",
      "classification": "Class III",
      "openfda": {
        "application_number": [
          "NDA004782"
        ],
        "brand_name": [
          "PREMARIN"
        ],
        "generic_name": [
          "ESTROGENS, CONJUGATED"
        ],
        "manufacturer_name": [
          "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."
        ],
        "product_ndc": [
          "0046-1100",
          "0046-1101",
          "0046-1102",
          "0046-1104",
          "0046-1103"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "ESTROGENS, CONJUGATED"
        ],
        "rxcui": [
          "150840",
          "197660",
          "197661",
          "197662",
          "202301",
          "208513",
          "208949",
          "310197",
          "403849",
          "404550"
        ],
        "spl_id": [
          "7273b788-92aa-4d38-8812-33edaf21bd42"
        ],
        "spl_set_id": [
          "258e1602-a3cf-4ccc-ca80-73dbbfb812ff"
        ],
        "package_ndc": [
          "0046-1101-81",
          "0046-1102-81",
          "0046-1102-91",
          "0046-1102-52",
          "0046-1104-81",
          "0046-1104-91",
          "0046-1100-81",
          "0046-1100-91",
          "0046-1100-52",
          "0046-1103-81"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0300461103815",
          "0300461101811"
        ],
        "nui": [
          "N0000175825",
          "N0000000100",
          "M0007792"
        ],
        "pharm_class_epc": [
          "Estrogen [EPC]"
        ],
        "pharm_class_moa": [
          "Estrogen Receptor Agonists [MoA]"
        ],
        "pharm_class_cs": [
          "Estrogens, Conjugated (USP) [CS]"
        ],
        "unii": [
          "IU5QR144QX"
        ]
      },
      "product_type": "Drugs",
      "event_id": "75225",
      "recalling_firm": "Pfizer Inc.",
      "address_1": "235 East 42nd Street",
      "address_2": "N/A",
      "postal_code": "10017-5703",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1528-2016",
      "product_description": "PREMARIN (conjugated estrogen tablets, USP) 1.25 mg, 1000- count bottle, Rx only, Distributed by: Wyeth Pharmaceuticals Inc. A subsidiary of Pfizer Inc. Philadelphia, PA 19101, NDC 0046-1104-91",
      "product_quantity": "1,316 bottles (1,316,000 tablets)",
      "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Bottles were incorrectly labeled with an expiry date of 11/17; the correct date is 09/17.",
      "recall_initiation_date": "20160915",
      "center_classification_date": "20160927",
      "termination_date": "20170809",
      "report_date": "20161005",
      "code_info": "Lot  # M35953S; Exp. 11/17 (labeled)."
    }
  ]
}